Search Within

Xiaoyu Li

Formats
  1. Journal Article (7)
  2. Meeting Abstract (2)
Groups
  1. Sloan Kettering Institute Postdocs (9)
  2. Surgery (9)
  3. Biostatistics Service (6)
  4. Epidemiology and Biostatistics (6)
  5. Department of Medicine (4)
  6. Solid Tumor Oncology Division (4)

More Groups

People
  1. Prasad Adusumilli (9)
  2. Navin Chintala (7)
  3. Kay See Tan (6)
  4. Rania Aly (5)
  5. Takashi Eguchi (4)
  6. David Jones (3)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2020 (1)
  4. 2019 (2)
  5. 2018 (3)
  6. 2017 (1)
Publications
  1. Journal of Thoracic Oncology (4)
  2. Frontiers in Oncology (2)
  3. Annals of Translational Medicine (1)
  4. Current Opinion in Immunology (1)
  5. Journal for ImmunoTherapy of Cancer (1)
Publishers
  1. Elsevier Inc. (5)
  2. Frontiers Media S.A. (2)
  3. AME Publishing Company (1)
  4. Biomed Central Ltd (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Organ-specific heterogeneity in tumor-infiltrating immune cells and cancer antigen expression in primary and autologous metastatic lung adenocarcinoma
    Journal Article

    Restle, D.; Dux, J.; Li, X.; Byun, A. J.; Choe, J. K.; Li, Y.; Vaghjiani, R. G.; Thomas, C.; Misawa, K.; Tan, K. S.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Tumor and tumor-associated macrophage programmed death-ligand 1 expression is associated with adjuvant chemotherapy benefit in lung adenocarcinoma
    Journal Article

    Gross, D. J.; Chintala, N. K.; Vaghjiani, R. G.; Grosser, R.; Tan, K. S.; Li, X.; Choe, J.; Li, Y.; Aly, R. G.; Emoto, K.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • gC1qR/HABP1/p32 is a potential new therapeutic target against mesothelioma
    Journal Article

    Peerschke, E.; Stier, K.; Li, X.; Kandov, E.; de Stanchina, E.; Chang, Q.; Xiong, Y.; Manova-Todorova, K.; Fan, N.; Barlas, A.; more...
    Frontiers in Oncology (2020)

    Fulltext@MSK | Save
  • Globular C1q receptor (gC1qR/p32/HABP1) is overexpressed in malignant pleural mesothelioma and is associated with increased survival in surgical patients treated with chemotherapy
    Journal Article

    Li, X.; Eguchi, T.; Aly, R. G.; Chintala, N. K.; Tan, K. S.; Zauderer, M. G.; Dembitzer, F. R.; Beasley, M. B.; Ghebrehiwet, B.; Adusumilli, P. S.; more...
    Frontiers in Oncology (2019)

    Fulltext@MSK | Save
  • Spread through air spaces (STAS) is prognostic in atypical carcinoid, large cell neuroendocrine carcinoma, and small cell carcinoma of the lung
    Journal Article

    Aly, R. G.; Rekhtman, N.; Li, X.; Takahashi, Y.; Eguchi, T.; Tan, K. S.; Rudin, C. M.; Adusumilli, P. S.; Travis, W. D.
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • gC1qR expression is independently prognostic for survival benefit following chemotherapy in mesothelioma
    Meeting Abstract

    Li, X.; Eguchi, T.; Aly, R.; Chintala, N.; Tan, K. S.; Messinger, J.; Zauderer, M.; Ghebrehiwet, B.; Adusumilli, P.; Peerschke, E.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Immune microenvironment and its association with adjuvant chemotherapy benefit in locoregionally advanced lung adenocarcinoma
    Meeting Abstract

    Vaghjiani, R.; Eguchi, T.; Chintala, N.; Li, X.; Aly, R.; Emoto, K.; Tan, K. S.; Jones, D.; Adusumilli, P.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Driving CARs on the uneven road of antigen heterogeneity in solid tumors
    Journal Article

    Chen, N.; Li, X.; Chintala, N. K.; Tano, Z. E.; Adusumilli, P. S.
    Current Opinion in Immunology (2018)

    Fulltext@MSK | Save
  • Novel immunotherapy clinical trials in malignant pleural mesothelioma
    Journal Article

    Tano, Z. E.; Chintala, N. K.; Li, X.; Adusumilli, P. S.
    Annals of Translational Medicine (2017)

    Fulltext@MSK | Save